MNPR Monopar Therapeutics Inc. - Common Stock
MNPR Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
MNPR Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Financial Health Debt, liquidity, solvency — balance sheet strength
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
MNPR Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
- Strong Buy 4 21.1%
- Buy 14 73.7%
- Hold 1 5.3%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
13 analysts · 2026-08-16Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| March 31, 2026 | $-0.46 | $-0.85 | 0.39% |
| Dec. 31, 2025 | $-0.64 | $-0.50 | -0.14% |
| Sept. 30, 2025 | $-0.48 | $-0.44 | -0.04% |
| June 30, 2025 | $-0.35 | $-0.48 | 0.13% |
| March 31, 2025 | $-0.38 | $-0.69 | 0.31% |
| Dec. 31, 2024 | $-2.75 | $-0.43 | -2.3% |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| MNPR | — | — | — | — | — | — |
| IMMX | $277M | -5.9 | — | — | -59.8% | — |
| RIGL | $784M | 2.2 | 64.1% | 124.7% | 155.1% | — |
| AURA | $347M | -3.1 | -29.7% | -1601.4% | -68.2% | — |
| FDMT | $432M | -3.1 | 230194.6% | -164.4% | -30.2% | — |
| ACHV | — | -4.0 | — | — | — | — |
| CTMX | $725M | — | -44.8% | -22.8% | -15.9% | — |
| NGNE | $319M | -4.9 | — | — | -33.6% | — |
| STTK | $231M | -5.2 | -82.5% | -4880.9% | -70.0% | — |
| RGNX | $733M | -3.8 | 104.5% | -113.8% | -122.5% | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 12
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | · | · | · | $0 | $0 | $0 | |
| R&D Expense | $10M | $13M | $6M | $8M | $6M | $4M | $2M | $2M | $935.3K | |
| SG&A Expense | $7M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | |
| Operating Expenses | $17M | $16M | $9M | $11M | $9M | $7M | $4M | $3M | $17M | |
| Operating Income | $-17M | $-16M | $-9M | $-11M | $-9M | $-7M | $-4M | $-3M | $-17M | |
| Interest Income | $3M | $404.0K | $429.0K | · | · | · | · | · | · | |
| Pretax Income | $-14M | $-16M | $-8M | · | · | · | · | $-3M | $-17M | |
| Income Tax | $800 | $800 | $800 | $800 | $0 | $18.4K | $0 | $-70.8K | $-3.6K | |
| Net Income | $-14M | $-16M | $-8M | $-11M | $-9M | $-6M | $-4M | $-3M | $-17M | |
| EPS (Basic) | $-1.85 | $-4.11 | $-3.04 | $-0.83 | · | · | · | · | · | |
| Shares (Basic) | 7,411,121 | 3,790,202 | 2,764,790 | 12,718,166 | 12,471,217 | · | · | · | · | |
| EBITDA | · | $-16M | $-9M | $-11M | $-9M | $-7M | $-4M | $-3M | · |
Balance Sheet 16
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $62M | $46M | $7M | $8M | $20M | $17M | $13M | $7M | $9M | |
| Other Current Assets | $63.7K | $78.9K | $66.4K | $46.0K | $217.7K | $62.7K | $15.7K | · | · | |
| Current Assets | $140M | $60M | $7M | $13M | $21M | $17M | $13M | $7M | $9M | |
| Other Non-current Assets | · | · | · | · | $0 | $68.9K | $122.4K | $65.7K | · | |
| Total Assets | $141M | $60M | $7M | $13M | $21M | $17M | $13M | $7M | $10M | |
| Accounts Payable | $3M | $2M | $2M | $3M | $2M | $1M | $724.2K | $399.6K | $311.9K | |
| Current Liabilities | $3M | $5M | $2M | $3M | $2M | $1M | $724.2K | $399.6K | $311.9K | |
| Capital Leases | $154.9K | $0 | $0 | $8.4K | $0 | · | · | · | · | |
| Total Liabilities | $3M | $5M | $2M | $3M | $2M | $1M | $724.2K | $399.6K | $311.9K | |
| Common Stock | $6.7K | $6.1K | $3.0K | $12.9K | $12.6K | $11.5K | $10.6K | $9.3K | $9.3K | |
| Paid-in Capital | · | · | · | $62M | $60M | $48M | $39M | $29M | $28M | |
| Retained Earnings | $-90M | $-76M | $-60M | $-52M | $-41M | $-32M | $-26M | $-22M | $-18M | |
| AOCI | $131.4K | $36.0K | $-14.1K | $8.9K | $-3.2K | $-7.9K | $-11.0K | $-2.4K | $0 | |
| Stockholders' Equity | $138M | $55M | $6M | $10M | $19M | $16M | $13M | $7M | $10M | |
| Liabilities + Equity | $141M | $60M | $7M | $13M | $21M | $17M | $13M | $7M | $10M | |
| Shares Outstanding | 6,692,140 | 6,102,560 | 2,980,900 | 12,946,573 | 12,598,125 | 11,453,465 | 10,587,632 | 9,291,421 | 9,291,421 |
Cash Flow 10
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $5M | $1M | $2M | $2M | · | · | · | · | · | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $-71.6K | $0 | |
| Operating Cash Flow | $-12M | $-6M | $-8M | $-7M | $-7M | $-5M | $-3M | $-3M | $-3M | |
| Investing Cash Flow | $-63M | $-14M | $5M | $-5M | $0 | · | · | · | · | |
| Stock Issued | $0 | $4M | $2M | $109.3K | · | $8M | $0 | $0 | $5M | |
| Stock Repurchased | $35M | $0 | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $4M | $2M | · | · | $8M | · | $0 | · | |
| Financing Cash Flow | $92M | $59M | $2M | $32.9K | $11M | $8M | $9M | $-206.3K | $10M | |
| Net Change in Cash | $16M | $39M | $-920.1K | $-12M | $4M | $4M | $6M | $-3M | $7M | |
| Taxes Paid | · | · | · | · | $0 | $-11.1K | $53 | · | · |
Profitability 6
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | -49611.0% | -37992.2% | -7947.2% | · | · | · | |
| Net Margin | · | · | · | -49511.0% | -37892.2% | -7697.7% | · | · | · | |
| EBITDA Margin | · | · | · | -49611.0% | -37992.2% | -7947.2% | · | · | · | |
| ROA | · | -46.1% | -81.7% | -62.3% | -48.7% | -41.7% | -40.9% | -37.4% | · | |
| ROE | · | -52.0% | -137.8% | -93.1% | -45.3% | -38.0% | -49.0% | -44.5% | · | |
| ROIC | · | -29.4% | · | · | · | · | · | -48.1% | · |
Liquidity & Solvency 2
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | · | 4.2 | 4.2 | · | 14.3 | 18.3 | 18.3 | · | |
| Quick Ratio | · | · | 4.1 | 2.6 | · | 14.2 | 18.2 | 17.3 | · |
Efficiency 1
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · |
Valuation (TTM) 6
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income TTM | $-14M | $-16M | $-8M | $-11M | $-9M | $-6M | $-4M | $-3M | $-17M | |
| Market Cap | · | $134M | $25M | $153M | $202M | $350M | $879M | · | · | |
| P/B | · | 2.4 | 4.5 | 15.2 | 10.7 | 22.3 | 69.6 | · | · | |
| P / Tangible Book | 3.2 | 2.4 | 4.5 | 15.2 | 10.7 | 22.3 | · | · | · | |
| P / Cash Flow | · | -21.0 | -3.2 | -21.2 | 27.6 | -75.2 | -291.2 | · | · |
Income Statement 10
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| R&D Expense | $5M | $3M | $4M | $3M | $2M | $2M | $10M | $984.3K | $1M | $966.1K | $1M | $1M | $2M | $2M | $2M | $2M | |
| SG&A Expense | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $590.6K | $657.8K | $757.3K | $876.4K | $749.5K | $733.5K | $871.7K | $806.0K | $675.1K | |
| Operating Expenses | $7M | $5M | $6M | $4M | $3M | $3M | $11M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $2M | |
| Operating Income | $-7M | $-5M | $-6M | $-4M | $-3M | $-3M | $-11M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-3M | $-2M | |
| Interest Income | $1M | $1M | $954.4K | $655.5K | $780.8K | $596.8K | $149.0K | $99.3K | $73.5K | $82.2K | $98.1K | $112.3K | · | · | · | · | |
| Net Income | $-5M | $-4M | $-5M | $-3M | $-2M | $-3M | $-11M | $-1M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-2M | |
| EPS (Basic) | $-0.62 | $-0.46 | $-0.64 | $-0.48 | $-0.35 | $-0.38 | $-2.74 | $-0.37 | $-0.49 | $-0.51 | $-2.00 | $-0.69 | $-0.16 | $-0.19 | $-0.23 | $-0.19 | |
| Shares (Basic) | 8,542,450 | 8,535,443 | -13,698,191 | 7,123,849 | 6,998,082 | 6,987,381 | -6,429,086 | 3,520,398 | 3,502,927 | 3,195,963 | -26,584,750 | 2,823,680 | 13,420,029 | 13,105,831 | 53,779 | 12,754,685 | |
| EBITDA | $-7M | $-5M | · | $-4M | $-3M | $-3M | · | $-2M | $-2M | $-2M | · | $-2M | $-2M | $-3M | · | $-2M |
Balance Sheet 15
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $53M | $53M | $62M | $128M | $40M | $40M | $46M | $6M | $6M | $8M | $7M | $6M | $7M | $6M | $8M | $14M | |
| Other Current Assets | $464.7K | $250.9K | $63.7K | $414.8K | $497.3K | $523.6K | $78.9K | $49.6K | $61.0K | $119.0K | $66.4K | $73.2K | $109.9K | $106.8K | $46.0K | $55.7K | |
| Current Assets | $135M | $138M | $140M | $144M | $54M | $55M | $60M | $6M | $7M | $9M | $7M | $9M | $10M | $12M | $13M | $14M | |
| Total Assets | $135M | $138M | $141M | $144M | $54M | $55M | $60M | $6M | $7M | $9M | $7M | $9M | $10M | $12M | $13M | $14M | |
| Accounts Payable | $4M | $2M | $3M | $3M | $2M | $1M | $2M | $1M | $1M | $1M | $2M | $2M | $3M | $3M | $3M | $2M | |
| Current Liabilities | $4M | $2M | $3M | $3M | $2M | · | $5M | · | · | · | · | $2M | $3M | $3M | $3M | $2M | |
| Capital Leases | $107.8K | $131.6K | $154.9K | $70.9K | $80.4K | · | $0 | · | · | · | · | $0 | $0 | $0 | $8.4K | $20.9K | |
| Total Liabilities | $4M | $3M | $3M | $3M | $2M | $1M | $5M | $1M | $1M | $1M | $2M | $2M | $3M | $3M | $3M | $2M | |
| Common Stock | $6.7K | $6.7K | $6.7K | $6.7K | $6.1K | $6.1K | $6.1K | $3.5K | $17.6K | $17.5K | $3.0K | $14.2K | $13.9K | $13.2K | $12.9K | $12.9K | |
| Paid-in Capital | · | · | · | · | · | · | · | · | · | · | · | · | · | $63M | · | $61M | |
| Retained Earnings | $-99M | $-93M | $-90M | $-84M | $-81M | $-78M | $-76M | $-65M | $-64M | $-62M | $-60M | $-58M | $-56M | $-54M | $-52M | $-49M | |
| AOCI | $91.3K | $98.5K | $131.4K | $11.7K | $77.6K | $-21.8K | $36.0K | $-11.0K | $8.3K | $4.2K | $-14.1K | $3.9K | $7.2K | $31.8K | $8.9K | $43.0K | |
| Stockholders' Equity | $131M | $135M | $138M | $142M | $52M | $54M | $55M | $5M | $6M | $7M | $6M | $7M | $8M | $9M | $10M | $13M | |
| Liabilities + Equity | $135M | $138M | $141M | $144M | $54M | $55M | $60M | $6M | $7M | $9M | $7M | $9M | $10M | $12M | $13M | $14M | |
| Shares Outstanding | 6,712,172 | 6,699,062 | 6,692,140 | 6,662,930 | 6,127,457 | 6,115,214 | 6,102,560 | 3,525,079 | 17,601,827 | 17,484,175 | 2,980,900 | 14,198,438 | 13,898,081 | 13,222,056 | 12,946,573 | 12,855,735 |
Cash Flow 8
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $1M | $2M | $1M | $1M | $1M | $1M | $278.6K | $199.1K | $334.4K | $328.7K | $474.2K | $474.1K | $473.3K | $476.2K | $393.4K | $390.7K | |
| Operating Cash Flow | $-3M | $-3M | $-3M | $-2M | $-1M | $-6M | $-2M | $-1M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-1M | $-2M | |
| Investing Cash Flow | $4M | $-6M | $-62M | $-2M | $1M | $-325.8K | $-14M | $985.7K | $-2.4K | $-983.3K | $3M | $-13.1K | $3M | $-983.4K | $-5M | $0 | |
| Stock Issued | · | · | $0 | $0 | $0 | $0 | $1M | $0 | $-1 | $3M | $339.9K | $254.9K | $657.8K | $821.6K | $109.3K | $0 | |
| Stock Repurchased | · | · | $0 | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | · | · | · | · | $0 | · | · | · | $3M | · | · | · | · | · | · | |
| Financing Cash Flow | $-647.4K | $-200.2K | $-384.7K | $92M | $-316.8K | $-115.7K | $56M | $-16.5K | $-9.9K | $3M | $334.5K | $246.7K | $641.2K | $804.8K | $138.7K | $-23.7K | |
| Net Change in Cash | $213.5K | $-9M | $-66M | $88M | $-209.5K | $-6M | $40M | $-99.8K | $-2M | $541.5K | $2M | $-2M | $1M | $-2M | $-6M | $-2M |
Profitability 5
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | -2434.6% | -2097.5% | · | -1840.4% | -1815.8% | -2790.5% | · | -31272.3% | |
| Net Margin | · | · | · | · | · | · | · | · | -2334.6% | -1997.5% | · | -1740.4% | -1715.8% | -2690.5% | · | -31172.3% | |
| EBITDA Margin | · | · | · | · | · | · | · | · | -2434.6% | -2097.5% | · | -1840.4% | -1815.8% | -2790.5% | · | -31272.3% | |
| ROA | -5.6% | -4.0% | · | -4.6% | -8.0% | -8.2% | · | -17.8% | -19.6% | -15.8% | · | -17.0% | -16.2% | -16.3% | · | -13.0% | |
| ROE | -5.8% | -4.1% | · | -4.7% | -8.4% | -8.6% | · | -22.6% | -24.6% | -20.0% | · | -20.4% | -19.7% | -18.8% | · | -14.2% |
Liquidity & Solvency 2
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 33.6 | 56.0 | · | 56.1 | 33.9 | · | · | · | · | · | · | 4.3 | 4.1 | 4.1 | · | 7.5 | |
| Quick Ratio | 13.1 | 21.4 | · | 49.7 | 24.9 | · | · | · | · | · | · | 2.8 | 2.9 | 2.0 | · | 7.5 |
Efficiency 1
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.0 | · | · | · | · | · | · | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 |
Valuation (TTM) 6
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | |
| Net Income TTM | $-15M | $-12M | · | $-10M | $-8M | $-7M | · | $-7M | $-8M | $-8M | · | $-9M | $-10M | $-10M | · | $-10M | |
| Market Cap | $621M | $367M | · | $544M | $219M | $223M | · | $24M | $64M | $60M | · | $44M | $59M | $92M | · | $98M | |
| P/B | 4.7 | 2.7 | · | 3.8 | 4.2 | 4.2 | · | 4.8 | 10.5 | 8.0 | · | 6.7 | 7.6 | 10.3 | · | 7.8 | |
| P / Tangible Book | 4.7 | 2.7 | · | 3.8 | 4.2 | 4.2 | · | 4.8 | 10.5 | 8.0 | · | 6.7 | 7.6 | 10.3 | · | 7.8 | |
| P / Cash Flow | · | -105.7 | · | · | · | -39.3 | · | · | · | -36.0 | · | · | · | -40.5 | · | · |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | — | — |
| Operating Margin % | — | — | — | -49611.0% | -37992.2% |
| Net Income | $-14M | $-16M | $-8M | $-11M | $-9M |
Balance Sheet
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Current Ratio | — | — | 4.2 | 4.2 | — |
| Quick Ratio | — | — | 4.1 | 2.6 | — |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 100 filers · $468.8M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 35 (+20 vs prior Q) | 14 (+5 vs prior Q) | 26 (-1 vs prior Q) | 24 (+2 vs prior Q) | -997K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | $72,062,327 | 1,317,410 | 15.37% | Shares |
| RA CAPITAL MANAGEMENT, L.P. | $61,776,696 | 667,207 | 13.18% | Shares |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $29,975,550 | 323,745 | 6.39% | Shares |
| Saturn V Capital Management LP | $28,885,858 | 311,976 | 6.16% | Shares |
| Siren, L.L.C. | $25,010,226 | 270,118 | 5.33% | Shares |
| ADAR1 Capital Management, LLC | $20,147,121 | 217,595 | 4.30% | Shares |
| Polar Capital Holdings Plc | $19,857,685 | 214,469 | 4.24% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $19,417,141 | 209,711 | 4.14% | Shares |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $19,369,365 | 209,195 | 4.13% | Shares |
| TCG Crossover Management, LLC | $18,826,047 | 203,327 | 4.02% | Shares |
| ORBIMED ADVISORS LLC | $14,575,796 | 157,423 | 3.11% | Shares |
| Candriam S.C.A. | $13,258,989 | 143,339 | 2.83% | Shares |
| Balyasny Asset Management L.P. | $12,457,336 | 134,543 | 2.66% | Shares |
| Alyeska Investment Group, L.P. | $9,259,000 | 100,000 | 1.97% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $8,975,407 | 96,907 | 1.91% | Shares |
| STATE STREET CORP | $8,569,297 | 92,551 | 1.83% | Shares |
| Vivo Capital, LLC | $8,379,395 | 90,500 | 1.79% | Shares |
| Driehaus Capital Management LLC | $7,781,264 | 84,040 | 1.66% | Shares |
| Vestal Point Capital, LP | $7,011,563 | 75,727 | 1.50% | Shares |
| WELLINGTON MANAGEMENT GROUP LLP | $6,686,294 | 72,214 | 1.43% | Shares |
| Longaeva Partners L.P. | $5,169,670 | 55,834 | 1.10% | Shares |
| MILLENNIUM MANAGEMENT LLC | $4,658,295 | 50,311 | 0.99% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $4,519,873 | 48,816 | 0.96% | Shares |
| Ikarian Capital, LLC | $4,431,450 | 47,861 | 0.95% | Shares |
| CITADEL ADVISORS LLC | $3,426,200 | 37,004 | 0.73% | Shares |
| NEUBERGER BERMAN GROUP LLC | $3,394,535 | 36,662 | 0.72% | Shares |
| Bank of New York Mellon Corp | $3,174,356 | 34,284 | 0.68% | Shares |
| STEMPOINT CAPITAL LP | $2,789,274 | 30,125 | 0.59% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $2,618,445 | 28,280 | 0.56% | Shares |
| UBS Group AG | $2,513,078 | 27,142 | 0.54% | Shares |
| VANGUARD GROUP INC | $1,873,914 | 28,697 | 0.40% | Shares |
| AMERIPRISE FINANCIAL INC | $1,648,102 | 17,800 | 0.35% | Shares |
| BOOTHBAY FUND MANAGEMENT, LLC | $1,360,055 | 14,689 | 0.29% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1,291,908 | 13,953 | 0.28% | Shares |
| Ishara Investments LP | $1,138,857 | 12,300 | 0.24% | Shares |
| TWO SIGMA INVESTMENTS, LP | $1,134,413 | 12,252 | 0.24% | Shares |
| Trexquant Investment LP | $1,111,450 | 12,004 | 0.24% | Shares |
| GOLDMAN SACHS GROUP INC | $738,498 | 7,976 | 0.16% | Shares |
| XTX Topco Ltd | $605,168 | 6,536 | 0.13% | Shares |
| Nuveen, LLC | $553,688 | 5,980 | 0.12% | Shares |
| RHUMBLINE ADVISERS | $521,271 | 5,630 | 0.11% | Shares |
| GERBER, LLC | $518,597 | 5,601 | 0.11% | Shares |
| Virtus Investment Advisers, LLC | $506,838 | 5,474 | 0.11% | Shares |
| RAYMOND JAMES FINANCIAL INC | $506,838 | 5,474 | 0.11% | Shares |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $490,727 | 5,300 | 0.10% | Shares |
| Aquatic Capital Management LLC | $354,342 | 3,827 | 0.08% | Shares |
| WELLS FARGO & COMPANY/MN | $352,953 | 3,812 | 0.08% | Shares |
| Engineers Gate Manager LP | $322,121 | 3,479 | 0.07% | Shares |
| BANK OF AMERICA CORP /DE/ | $300,918 | 3,250 | 0.06% | Shares |
| MetLife Investment Management, LLC | $269,252 | 2,908 | 0.06% | Shares |
| ALLIANCEBERNSTEIN L.P. | $260,800 | 4,760 | 0.06% | Shares |
| EP Wealth Advisors, LLC | $241,012 | 2,603 | 0.05% | Shares |
| Entropy Technologies, LP | $240,734 | 2,600 | 0.05% | Shares |
| WINTON GROUP Ltd | $231,475 | 2,500 | 0.05% | Shares |
| GABELLI FUNDS LLC | $231,475 | 2,500 | 0.05% | Shares |
| AMERICAN CENTURY COMPANIES INC | $228,605 | 2,469 | 0.05% | Shares |
| NEW YORK STATE COMMON RETIREMENT FUND | $222,216 | 2,400 | 0.05% | Shares |
| Martin Investment Management, LLC | $215,457 | 2,327 | 0.05% | Shares |
| Schonfeld Strategic Advisors LLC | $213,882 | 2,310 | 0.05% | Shares |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $192,217 | 2,076 | 0.04% | Shares |
| CITIGROUP INC | $169,255 | 1,828 | 0.04% | Shares |
| Invesco Ltd. | $165,088 | 1,783 | 0.04% | Shares |
| DIADEMA PARTNERS LP | $150,922 | 1,630 | 0.03% | Shares |
| Vanguard Global Advisers, LLC | $143,792 | 1,553 | 0.03% | Shares |
| Quarry LP | $139,070 | 1,502 | 0.03% | Shares |
| Police & Firemen's Retirement System of New Jersey | $135,922 | 1,468 | 0.03% | Shares |
| AlphaQuest LLC | $129,490 | 1,983 | 0.03% | Shares |
| MEEDER ASSET MANAGEMENT INC | $128,608 | 1,389 | 0.03% | Shares |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $124,996 | 1,350 | 0.03% | Shares |
| BlackRock, Inc. | $115,460 | 1,247 | 0.02% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $68,609 | 741 | 0.01% | Shares |
| BARCLAYS PLC | $66,387 | 717 | 0.01% | Shares |
| NORTHERN TRUST CORP | $65,554 | 708 | 0.01% | Shares |
| NewEdge Advisors, LLC | $55,554 | 600 | 0.01% | Shares |
| FMR LLC | $49,073 | 530 | 0.01% | Shares |
| Legal & General Group Plc | $43,054 | 465 | 0.01% | Shares |
| Persistent Asset Partners Ltd | $38,147 | 412 | 0.01% | Shares |
| Ameritas Investment Partners, Inc. | $37,869 | 409 | 0.01% | Shares |
| Tower Research Capital LLC (TRC) | $31,944 | 345 | 0.01% | Shares |
| Creative Planning | $31,295 | 338 | 0.01% | Shares |
| JPMORGAN CHASE & CO | $18,628 | 197 | 0.00% | Shares |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $13,533 | 247 | 0.00% | Shares |
| ROYAL BANK OF CANADA | $13,000 | 136 | 0.00% | Shares |
| Allworth Financial LP | $10,278 | 111 | 0.00% | Shares |
| Russell Investments Group, Ltd. | $9,815 | 106 | 0.00% | Shares |
| C M BIDWELL & ASSOCIATES LTD | $8,703 | 94 | 0.00% | Shares |
| DEUTSCHE BANK AG\ | $8,333 | 90 | 0.00% | Shares |
| Sterling Capital Management LLC | $6,666 | 72 | 0.00% | Shares |
| MERCER GLOBAL ADVISORS INC /ADV | $3,333 | 36 | 0.00% | Shares |
| Global Retirement Partners, LLC | $2,963 | 32 | 0.00% | Shares |
| GAMMA Investing LLC | $2,315 | 25 | 0.00% | Shares |
| Farther Finance Advisors, LLC | $2,222 | 24 | 0.00% | Shares |
| CWM, LLC | $822 | 15 | 0.00% | Shares |
| GSA CAPITAL PARTNERS LLP | $697 | 7,532 | 0.00% | Shares |
| MORGAN STANLEY | $556 | 6 | 0.00% | Shares |
| US BANCORP \DE\ | $556 | 6 | 0.00% | Shares |
| PNC Financial Services Group, Inc. | $556 | 6 | 0.00% | Shares |
| PRICE T ROWE ASSOCIATES INC /MD/ | $343 | 3,699 | 0.00% | Shares |
| Arax Advisory Partners | $278 | 3 | 0.00% | Shares |
| Integrated Wealth Concepts LLC | $93 | 1 | 0.00% | Shares |
Company insiders 4 insiders · 3 officers · 2 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Robinson Chandler | Chief Executive Officer | June 30, 2026 M | 99,267 | 0 | 0 | $0 |
| Quan Anh Vu | Chief Financial Officer | June 30, 2026 M | 2,221 | 0 | 0 | $0 |
| Andrew Cittadine | Chief Operating Officer | June 30, 2026 M | 55,614 | 0 | 0 | $0 |
| Nicole Sweeny | Director | June 26, 2026 A | — | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
Activists & 5%+ owners 3 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Tactic Pharma LLC, Robinson Chandler, Brown Michael J ×4 filings | Jan. 30, 2026 | 4.50% | Amendment | — | SEC |
| Monopar Therapeutics, Hendricks Diane, Leo Karl, Pharma Investments LLC | Feb. 7, 2025 | 13.40% | Amendment | — | SEC |
| GEM PHARMACEUTICALS LLC, DIANE HENDRICKS, KARL LEO, ARTHUR KLAUSNER, PHARMA INVESTMENTS LLC | Dec. 23, 2019 | — | Initial filing | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF ownership Held by 21 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0.52% | 3,699 NS | April 30, 2026 | N-PORT |
| IWC · iShares Trust | 0.12% | 15,284 SH | Aug. 8, 2026 | Daily |
| VFMO · VANGUARD WELLINGTON FUND | 0.08% | 18,350 SH | Aug. 8, 2026 | Daily |
| IWN · iShares Trust | 0.03% | 31,439 SH | Aug. 8, 2026 | Daily |
| GSSC · Goldman Sachs ETF Trust | 0.02% | 3,112 NS | May 31, 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.02% | 2,949 SH | Aug. 8, 2026 | Daily |
| IWM · iShares Trust | 0.02% | 116,348 SH | Aug. 8, 2026 | Daily |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 25,913 SH | Aug. 8, 2026 | Daily |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.01% | 1,184 SH | Aug. 8, 2026 | Daily |
| IWO · iShares Trust | 0.01% | 10,218 SH | Aug. 8, 2026 | Daily |
| ITWO · ProShares Trust | 0.01% | 208 NS | May 31, 2026 | N-PORT |
| RSSL · Global X Funds | 0.01% | 1,948 NS | April 30, 2026 | N-PORT |
| UWM · ProShares Trust | 0.00% | 163 NS | May 31, 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0.00% | 1,318 NS | May 31, 2026 | N-PORT |
| URTY · ProShares Trust | 0.00% | 162 NS | May 31, 2026 | N-PORT |
| ITOT · iShares Trust | 0.00% | 9,937 SH | Aug. 8, 2026 | Daily |
| HDG · ProShares Trust | 0.00% | 4 NS | May 31, 2026 | N-PORT |
| IWV · iShares Trust | 0.00% | 1,833 SH | Aug. 8, 2026 | Daily |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 45,173 SH | Aug. 8, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 159,786 SH | Aug. 8, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 420 SH | Aug. 8, 2026 | Daily |